Clinical trial

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

NCT00876343

Study summary

ClinicalTrials.gov

Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Aripiprazole (Fixed dose) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Aripiprazole (Titrated dose) Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-03-01

PhasePHASE3

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

Aripiprazole (Fixed dose)DRUG

Aripiprazole (Titrated dose)DRUG

PlaceboDRUG

Sponsors & collaborators

Otsuka Pharmaceutical Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00876343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.